Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Mephisto who wrote (1640)	2/7/2000 10:50:00 AM
From: Sonki	Read Replies (1) \| Respond to of 1722

some women do use Viagra. DLJ raises Pfizer, cuts WLA NEW YORK, Feb 7 (Reuters) - Donaldson Lufkin & Jenrette said Monday it raised its investment opinion on shares of Pfizer Inc. (NYSE:PFE - news) and downgraded Warner-Lambert Co. (NYSE:WLA - news) after the drug giants agreed to a $90 billion merger. -- DLJ upgraded Pfizer to market performance from underperformance. -- DLJ cut Warner-Lambert to market performance from buy. -- No further details were immediately available. -- Early Monday, Pfizer said it would buy rival Warner-Lambert for $90 billion in stock to create the No. 1 U.S. drug maker and the second largest drug maker in the world. That followed a three-month takeover battle. Warner-Lambert terminated its deal with American Home Products Corp. (NYSE:AHP - news) by paying a break-up fee of $1.8 billion -- the largest such fee ever paid and nearly as much as AHP earned, excluding charges, in 1999 and 1998. -- Pfizer shares gained 1/2 to trade at 36-3/8, up from a low of 30-5/8 but off a high of 50. Warner-Lambert shares rose 1-1/2 to 96-1/4 and struck an intraday high of 97-1/8. AHP climbed 2-1/4 to 47-3/4, off a high of 70-1/4.